Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Competitions such as model exhibitions, poster presentations, and prototype displays highlighted the creativity and ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that three of its research abstracts have been accepted for poster ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today ...

Onc.AI, a digital health company developing AI-powered oncology clinical management solutions, today announced that new validation study results from research collaborations with Pfizer, Baylor Scott ...

An AI model has been developed to predict the degree of height growth after treatment with growth hormone drugs. LG Chem said ...

Presentation to Highlight Genprex's Study of Reqorsa® Gene Therapy in Combination with Tecentriq® for the Treatment of Exten ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

Germany weighs 10% tax on internet giants like Google, Meta. Federal appeals court issues stay on Trump tariffs ruling. Red ...

Through the American Heart Association’s Rural Health Care Outcomes Accelerator, rural hospitals are leveraging peer learning to improve cardiovascular and stroke outcomes.